Norovirus vaccine induces a cross-genotype protective immune response

• J. Sherwood,
• I. Sonderegger,
• R. Braun,
• A. Brinkman,
• R. Baric,
• L. Lindesmith

Affiliations

J. Sherwood

Takeda, Vaccines Business Unit, Zurich, Switzerland; Corresponding author.

I. Sonderegger

Takeda, Vaccines Business Unit, Zurich, Switzerland

R. Braun

Takeda, Vaccines Business Unit, Discovery, Cambridge, United States

A. Brinkman

Takeda, Vaccines Business Unit, Discovery, Cambridge, United States

R. Baric

University of North Carolina, Epidemiology, Chapel Hill, United States

L. Lindesmith

University of North Carolina, Epidemiology, Chapel Hill, United States